Home › Lymphoma › District of Columbia
Lymphoma clinical trials in District of Columbia
7 studies for Lymphoma are looking for participants at sites in District of Columbia.
Cities in District of Columbia
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- Georgetown University, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06084936A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- MedStar Georgetown University Hospital, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07188558Mosaic Trial for Stem Cell Transplant Recipients
- Georgetown University School of Medicine, Washington D.C.
Recruiting
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06960993CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Children's National Medical Center, Washington D.C.
RecruitingPhase 1/2
12 Months – 21 Years · All sexes · Updated Sep 11, 2026 · NCT04870944Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Medstar Georgetown University Hospital, Washington D.C.
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
- Georgetown University (Data Collection Only), Washington D.C.
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT05389293Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- George Washington University, Washington D.C.
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT05663502From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.